The hugely popular medications Ozempic and Wegovy​, used for diabetes and weight loss, will be included in the next round of talks to negotiate lower Medicare drug prices.
On its last weekday in power, the Biden Administration has chosen the next batch of drugs up for price negotiation in ...
The Inflation Reduction Act (IRA) of 2022 brought substantial modifications to the Medicare program, which are still reflected in 2025. One of these changes was a new limit for ded ...
Ozempic and Wegovy, the blockbuster but costly GLP-1 drugs often used for weight loss, are among the 15 medications that will ...
Diabetes and weight loss drugs Ozempic and Wegovy have been added to the list of medications selected for Medicare price ...
Medicare recipients who take expensive prescriptions will get a break this year with a $2,000 cap on drug costs.
Millions of Medicare enrollees are likely to see relief in 2025 when a $2,000 cap on out-of-pocket prescription drug-spending goes into effect.
Just how much Medicare price negotiations will negatively impact Novo Nordisk, though, depends on what the final negotiated ...
Novo Nordisk expects Ozempic, which has been on the market since 2017, will be on Medicare's list of drugs to negotiate ...
If you’re steamed to discover your favorite doctor is no longer in your Medicare Advantage plan’s network, now is the time to make a change. Medicare Advantage enrollees can switch plans or transfer ...